Events
Join Pharsight at
ACOP: May 12-15
Pharsight-Simcyp Webinar
Modeling and Simulation in Pediatric Drug Development
View Webcast
Software Products
Products
New QRPEM algorithm released for Phoenix NLME - faster, more accurate than existing mixed effects modeling methods due to a vastly improved sampling method.
Learn more
With Phoenix Connect, get increased support for integrated workflows that include NONMEM, SAS, S+ or R, allowing Phoenix to more fully support pharmacometrics workflows.
Learn more
Consulting Services
Services
Our global team of scientists applies quantitative analysis and predictive models of diseases, drugs and clinical trials to support strategic decisions and new drug submissions.
Recently Presented/Published
A Literature-based Glucose-Insulin Model: Application to Evaluate Dose-Titration Schemes in Phase II (WCoP 2012). More
Dealing with excess of zeroes in the statistical analysis of MRI lesion count in Multiple Sclerosis (in Pharm Stat). More
Pharsight software products and services facilitate improved productivity and strategic decision making in drug development.
Since the company’s founding in 1995, our goal remains to help customers reduce the time, cost and risk of drug development. With more than 1200 customers worldwide, Pharsight products and services are used by all of the world’s top 50 drug development organizations. Pharsight software improves the value and availability of preclinical and clinical program data for PK/PD modeling, analysis, data management, and reporting. Pharsight Consulting Services is the world’s largest and most experienced pharmacometric consulting group, a global team of experts dedicated to supporting strategic development decisions and submission-ready analyses for new drug approval.